Wakamoto Pharmaceutical Co.,Ltd. (TYO:4512)
Japan · Delayed Price · Currency is JPY 312.00
-12.00 (-3.70%)
Feb 13, 2026, 3:30 PM JST
Wakamoto Pharmaceutical Market Cap
Wakamoto Pharmaceutical has a market cap or net worth of 10.86 billion as of February 13, 2026. Its market cap has increased by 36.84% in one year.
Market Cap
10.86B
Enterprise Value
n/a
Revenue
9.43B
Ranking
n/a
PE Ratio
n/a
Stock Price
312.00
Market Cap Chart
Since August 18, 1993, Wakamoto Pharmaceutical's market cap has decreased from 27.21B to 10.86B, a decrease of -60.11%. That is a compound annual growth rate of -2.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 10.86B | 9.09% |
| Dec 30, 2025 | 9.95B | 27.68% |
| Dec 30, 2024 | 7.79B | 5.16% |
| Dec 29, 2023 | 7.41B | -4.05% |
| Dec 30, 2022 | 7.72B | -28.85% |
| Dec 30, 2021 | 10.86B | 28.40% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fuso Pharmaceutical Industries,Ltd. | 20.28B |
| Pharma Foods International | 19.28B |
| Taiko Pharmaceutical | 15.18B |
| Morishita Jintan | 9.47B |
| Solasia Pharma K.K. | 7.90B |
| Cyfuse Biomedical K.K. | 6.83B |
| MedRx | 6.71B |
| WDB coco | 6.51B |